Literature DB >> 9038144

Site-directed mutagenesis of glutamate 166 in two beta-lactamases. Kinetic and molecular modeling studies.

G Guillaume1, M Vanhove, J Lamotte-Brasseur, P Ledent, M Jamin, B Joris, J M Frère.   

Abstract

The catalytic pathway of class A beta-lactamases involves an acyl-enzyme intermediate where the substrate is ester-linked to the Ser-70 residue. Glu-166 and Lys-73 have been proposed as candidates for the role of general base in the activation of the serine OH group. The replacement of Glu-166 by an asparagine in the TEM-1 and by a histidine in the Streptomyces albus G beta-lactamases yielded enzymes forming stable acyl-enzymes with beta-lactam antibiotics. Although acylation of the modified proteins by benzylpenicillin remained relatively fast, it was significantly impaired when compared to that observed with the wild-type enzyme. Moreover, the E166N substitution resulted in a spectacular modification of the substrate profile much larger than that described for other mutations of Omega-loop residues. Molecular modeling studies indicate that the displacement of the catalytic water molecule can be related to this observation. These results confirm the crucial roles of Glu-166 and of the "catalytic" water molecule in both the acylation and the deacylation processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038144     DOI: 10.1074/jbc.272.9.5438

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  A QM/MM study on the enzymatic inactivation of cefotaxime.

Authors:  Ignacio Lizana; Eduardo J Delgado
Journal:  J Mol Model       Date:  2017-06-20       Impact factor: 1.810

2.  Dynamical aspects of TEM-1 beta-lactamase probed by molecular dynamics.

Authors:  Danilo Roccatano; Gianluca Sbardella; Massimiliano Aschi; Gianfranco Amicosante; Cecilia Bossa; Alfredo Di Nola; Fernando Mazza
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

3.  The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.

Authors:  Meha P Patel; Liya Hu; Vlatko Stojanoski; Banumathi Sankaran; B V Venkataram Prasad; Timothy Palzkill
Journal:  Biochemistry       Date:  2017-06-27       Impact factor: 3.162

4.  TEM-1 backbone dynamics-insights from combined molecular dynamics and nuclear magnetic resonance.

Authors:  Olivier Fisette; Sébastien Morin; Pierre-Yves Savard; Patrick Lagüe; Stéphane M Gagné
Journal:  Biophys J       Date:  2010-02-17       Impact factor: 4.033

5.  Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.

Authors:  Nicholas G Brown; Dar-Chone Chow; Banumathi Sankaran; Peter Zwart; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

Review 6.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 7.  Development of an effective protein-labeling system based on smart fluorogenic probes.

Authors:  Shahi Imam Reja; Masafumi Minoshima; Yuichiro Hori; Kazuya Kikuchi
Journal:  J Biol Inorg Chem       Date:  2019-05-31       Impact factor: 3.358

8.  Crystal structure of the Mycobacterium fortuitum class A beta-lactamase: structural basis for broad substrate specificity.

Authors:  Eric Sauvage; Eveline Fonzé; Birgit Quinting; Moreno Galleni; Jean-Marie Frère; Paulette Charlier
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

9.  pKa calculations for class A beta-lactamases: methodological and mechanistic implications.

Authors:  X Raquet; V Lounnas; J Lamotte-Brasseur; J M Frère; R C Wade
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

10.  Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.

Authors:  Soichiro Kimura; Masaji Ishiguro; Yoshikazu Ishii; Jimena Alba; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.